Innovation Crossroads: Tech, Business, and Global Impact

National fencer Saif Nordin partners with Dr.stretch, bringing elite athletic recovery to the public to combat a national mobility issue costing millions.

At CES 2026, Chinese robotics firm RoboCT unveiled a bold strategy to turn exoskeletons from medical aids into everyday 'new organs' for all.

A new AI assistant, trained only on US financial regulations, aims to revolutionize compliance for banks by promising speed, security, and affordability.

Nominated for a top OCBJ award, Marla Noel’s journey from founder to growth advisor reveals a blueprint for 'drama free' success in business and community.

All four founding partners of SBSB Eastham have been named to the prestigious 2026 Lawdragon 500, a rare feat underscoring their firm's dominance.

With final approval for its C$3.3 billion acquisition by GTCR, Dentalcorp's move to private ownership is set to reshape Canada's dental landscape.

A new partnership aims to move AI from costly experiments to real-world value in biopharma, combining specialized agents with strategic implementation.

With new funding and a veteran biotech leader, Montreal's Find Therapeutics advances its first-in-class therapy aimed at reversing nerve damage in MS.

Brookfield Asset Management renews its major share buyback plan, a strategic signal of confidence aimed at boosting shareholder value amid market shifts.

A new AI-designed vaccine, TG4050, has prevented relapse in all head and neck cancer patients in a key trial, signaling a breakthrough in personalized medicine.

At CES 2026, an awards ceremony marks two decades of upheaval, chronicling China's rise from follower to leader in the global electronics industry.

As stronger, cheaper vapes fuel a youth addiction crisis, a new initiative reframes relapse and offers digital tools to help Gen Z finally break free.

At CES 2026, Hitachi unveiled major AI alliances with NVIDIA and Google, betting its HMAX platform can embed intelligence into the world's core systems.

At CES 2026, LumiMind's BCI tech promises to guide you to sleep and power thought-controlled games, raising major scientific and ethical questions.

CES 2026: A new platform, Liquid Canvas, aims to liberate digital art from brand-locked TVs, offering a universal subscription for any screen.

Acertis Pharmaceuticals secures rights to Licart, a unique once-daily NSAID patch, aiming to disrupt the competitive U.S. topical pain relief market.

Employee-owned SSC CPAs + Advisors merges with Oklahoma's Harrison Henderson, expanding its footprint and bringing its unique ownership model to new markets.

A major new partnership aims to consolidate the industrial services sector, fueled by private equity and a national infrastructure spending boom.

Global insurer Starr commits to a 275,000 sq ft headquarters in BXP's new sustainable tower, a major vote of confidence in Midtown Manhattan's future.

China's EngineAI unveils its powerful T800 humanoid at CES 2026, backed by massive funding and signaling a new era in the global robotics race.